CA3180205A1 - Use of surfactant protein d to treat viral infections - Google Patents

Use of surfactant protein d to treat viral infections

Info

Publication number
CA3180205A1
CA3180205A1 CA3180205A CA3180205A CA3180205A1 CA 3180205 A1 CA3180205 A1 CA 3180205A1 CA 3180205 A CA3180205 A CA 3180205A CA 3180205 A CA3180205 A CA 3180205A CA 3180205 A1 CA3180205 A1 CA 3180205A1
Authority
CA
Canada
Prior art keywords
rhsp
protein
pharmaceutical composition
cov
sars
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3180205A
Other languages
English (en)
French (fr)
Inventor
Paul Kingma
Shawn GRANT
Raquel Arroyo-Rodriguez
Marc SALZBERG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Airway Therapeutics Inc
Original Assignee
Airway Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Airway Therapeutics Inc filed Critical Airway Therapeutics Inc
Publication of CA3180205A1 publication Critical patent/CA3180205A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CA3180205A 2020-04-22 2021-04-20 Use of surfactant protein d to treat viral infections Pending CA3180205A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063013726P 2020-04-22 2020-04-22
US63/013,726 2020-04-22
US202063072354P 2020-08-31 2020-08-31
US63/072,354 2020-08-31
PCT/US2021/028207 WO2021216584A1 (en) 2020-04-22 2021-04-20 Use of surfactant protein d to treat viral infections

Publications (1)

Publication Number Publication Date
CA3180205A1 true CA3180205A1 (en) 2021-10-28

Family

ID=78270057

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3180205A Pending CA3180205A1 (en) 2020-04-22 2021-04-20 Use of surfactant protein d to treat viral infections

Country Status (10)

Country Link
US (1) US20230181697A1 (https=)
EP (1) EP4138905A4 (https=)
JP (1) JP7798791B2 (https=)
KR (1) KR20230019089A (https=)
AU (1) AU2021258178A1 (https=)
BR (1) BR112022021423A2 (https=)
CA (1) CA3180205A1 (https=)
IL (1) IL297362A (https=)
MX (1) MX2022013195A (https=)
WO (1) WO2021216584A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2023145916A1 (https=) * 2022-01-31 2023-08-03
WO2024097169A1 (en) * 2022-11-01 2024-05-10 National Jewish Health Treatment of coronavirus infections with antimicrobial phospholipid compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933032B2 (en) * 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
US20030221199A1 (en) 1998-10-20 2003-11-27 Whitsett Jeffrey A. Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
US20120220531A1 (en) * 2011-02-04 2012-08-30 Cincinnati Children's Hospital Medical Center Surfactant protein d for the treatment of disorders associated with lung injury
US20130216499A1 (en) * 2012-02-17 2013-08-22 Wenlin Huang Compositions of recombinant human endostatin adenovirus injections and methods of production
NL2011626C2 (en) * 2013-10-17 2015-04-20 Stichting Tech Wetenschapp Novel polypeptide and uses thereof.
JP7797098B2 (ja) * 2018-03-29 2026-01-13 エアウェイ・セラピューティクス・インコーポレイテッド サーファクタントタンパク質ｄ（ｓｐ－ｄ）を含む方法及び組成物
WO2020247675A1 (en) * 2019-06-06 2020-12-10 Spiritus Therapeutics, Inc. Methods for attenuating viral infection and for treating lung injury
KR102205028B1 (ko) * 2020-03-22 2021-01-20 (주)셀트리온 사스-코로나바이러스-2에 중화 활성을 갖는 결합 분자
US11123329B1 (en) * 2020-03-23 2021-09-21 Vicore Pharma Ab Use of angiotensin II type 2 receptor agonist
CN112481417B (zh) * 2020-12-24 2022-05-27 山西大学 新冠肺炎病毒分型及突变位点快速检测方法及试剂盒

Also Published As

Publication number Publication date
KR20230019089A (ko) 2023-02-07
JP2023523253A (ja) 2023-06-02
US20230181697A1 (en) 2023-06-15
EP4138905A4 (en) 2024-04-17
BR112022021423A2 (pt) 2023-01-03
JP7798791B2 (ja) 2026-01-14
AU2021258178A1 (en) 2022-11-17
EP4138905A1 (en) 2023-03-01
IL297362A (en) 2022-12-01
MX2022013195A (es) 2023-01-05
WO2021216584A1 (en) 2021-10-28

Similar Documents

Publication Publication Date Title
TWI457132B (zh) 含表面活性蛋白ｂ（ｓｐ－ｂ）及表面活性蛋白ｃ（ｓｐ－ｃ）類似物之改良重組表面活性劑組成物
US20190309021A1 (en) Composition Comprising a Peptide and an Inhibitor of Viral Neuraminidase
CN102834115B (zh) 用于治疗流感的重组人cc10蛋白
JP7286319B6 (ja) エラスターゼ阻害活性を有するベータヘアピンペプチド模倣体及びそのエアロゾル剤形
CA3180205A1 (en) Use of surfactant protein d to treat viral infections
JP2021519757A (ja) サーファクタントタンパク質ｄ（ｓｐ−ｄ）を含む方法及び組成物
US12226474B2 (en) Methods and compositions for treating infections
EP4294454B1 (en) Anti-viral peptides and compositions and methods of use thereof
JPH05509301A (ja) 肺胞界面活性タンパク質
CN114846020B (zh) 逆向-反转肽
JP2013537168A (ja) 慢性肺疾患の処置のためのトレフォイル因子（ｔｆｆ）
JP2002529394A (ja) 肺サーファクタント組成物を含有する治療セット
KR102395835B1 (ko) 재구성된 폐 계면활성제 조성물을 포함하는 안정한 약제학적 제제
US11299518B2 (en) Fusion respiratory syncytial virus inhibitors and use thereof
US12534514B2 (en) Biological and synthetic molecules inhibiting respiratory syncytial virus infection
US20240108735A1 (en) Methods and compositions for treating covid infections
CN119156396A (zh) 用于治疗covid感染的方法和组合物
EP4121087A1 (en) Compositions of anti-viral peptides and methods of use thereof
US11161881B2 (en) Composition comprising a peptide and an inhibitor of viral neuraminidase
TW202607013A (zh) 一種包含ｐｓｄ－９５多肽抑制劑的醫藥組成物及其製備方法
WO2024050300A2 (en) Synthetic surfactants for inhibiting coronavirus infection
WO2019067887A1 (en) ENAC INHIBITOR PEPTIDES AND USES THEREOF
HK1185274A1 (en) Reconstituted surfactants having improved properties

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD

Year of fee payment: 4

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250411

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250411

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20250422

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT

Effective date: 20250422

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250422

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250423

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250619

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20250619

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250619

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250619

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250619